Potential New Neuroblastoma Treatment
Exciting news posted by St Baldrick's: the long-term study for the biology- and response-based algorithm on the Children's Oncology Group study ANBL0531 for intermediate risk neuroblastoma is complete and the results have been officially published! In the long-term study, a ten year period, the overall survival rate was 95%, with an event-free survival rate of 82%, which is fantastic!
Read the summary here.
Comments
Post a Comment